ClinConnect ClinConnect Logo
Search / Trial NCT06938425

Effectiveness of Percutaneous Electrolysis and Dry Needling vs. Standard Therapy for Whiplash Syndrome

Launched by CAMILO JOSE CELA UNIVERSITY · Apr 14, 2025

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

Percutaneous Electrolysis Dry Needling Whiplash Myofascial Pain Syndrome Myofascial Trigger Point Intrafibrillar Blood Flow Elasticity

ClinConnect Summary

This clinical trial is studying the effectiveness of two specific treatments, called percutaneous electrolysis (PIE) and deep dry needling (DDN), compared to standard physiotherapy for adults suffering from whiplash injuries after a traffic accident. The goal is to see if these new treatments can help reduce pain and improve muscle function better than the usual therapy. The researchers will also look at how these treatments affect blood flow and muscle elasticity over time as reported by the patients.

To be eligible for the trial, participants must be adults living in the Autonomous Community of Melilla who have neck pain from a traffic accident and at least one painful area in their neck muscles. They should have a moderate level of pain, rated 5 or higher on a scale. However, certain individuals will not be able to participate, including those on blood-thinning medication, those with previous neck injuries or surgeries, and pregnant women. If you decide to take part, you can expect to receive one of the treatment options and help researchers learn more about the best ways to treat whiplash injuries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults with whiplash syndrome following a traffic accident.
  • Patients must reside or stay in the Autonomous Community of Melilla during the intervention phase.
  • Subjects will have the presence of neck pain after suffering a traffic accident and the presence of at least one active trigger point in the sternocleidomastoid and/or levator scapulae muscles.
  • All subjects who suffer a traffic accident and who have a score of 5 or higher on the numerical scale (EN) of pain assessment.
  • Exclusion Criteria:
  • Patients undergoing anticoagulant treatment.
  • Patients who have suffered previous cervical trauma or who have undergone surgery in the last year.
  • Subjects who present some type of alteration (skin or infection, sensitivity or pain perception).
  • Subjects with central or peripheral nervous system involvement.
  • Patients who have problems with the material: allergy to metal, belonephobia (fear of needles).
  • Pregnant women.

About Camilo Jose Cela University

Camilo José Cela University is a renowned institution dedicated to advancing education and research in various fields, including health sciences. With a commitment to fostering innovation and excellence, the university actively engages in clinical trials that aim to enhance medical knowledge and improve patient outcomes. Its multidisciplinary approach brings together expert faculty, state-of-the-art facilities, and a focus on ethical standards, ensuring that all research conducted under its auspices is rigorous, transparent, and aligned with the highest academic and clinical practices. Through these efforts, Camilo José Cela University strives to contribute meaningfully to the scientific community and the advancement of healthcare.

Locations

Patients applied

0 patients applied

Trial Officials

María Benito, PhD

Study Director

Associate Professor

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported